NEW YORK--(BUSINESS WIRE)--Medidata Solutions (Nasdaq: MDSO), a leading global provider of hosted clinical development solutions, today announced that the underwriters of its initial public offering exercised in full their over-allotment option to purchase an additional 945,000 shares of Medidata’s common stock at a public offering price of $14.00 per share, less underwriting discounts and commissions, from certain selling stockholders. The option was granted in connection with Medidata’s initial public offering of 6,300,000 shares of its common stock, which priced on June 24, 2009. The closing of the sale of all of the 7,245,000 shares by Medidata and the selling stockholders to the underwriters occurred earlier today.
